March 1, 2018 / 9:07 PM / 6 months ago

BRIEF-Sarepta Therapeutics Reports Q4 Non-GAAP Loss Per Share $0.28

March 1 (Reuters) - Sarepta Therapeutics Inc:

* SAREPTA THERAPEUTICS ANNOUNCES FOURTH QUARTER 2017 AND FULL-YEAR 2017 FINANCIAL RESULTS AND RECENT CORPORATE DEVELOPMENTS

* Q4 NON-GAAP LOSS PER SHARE $0.28

* Q4 REVENUE $57.3 MILLION

* Q4 EARNINGS PER SHARE VIEW $-0.32, REVENUE VIEW $56.5 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below